• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER (ISRAEL) LTD. CARTO® 3 SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number M-4800-01
Device Problem Electrical /Electronic Property Problem (1198)
Patient Problems Atrial Fibrillation (1729); Cardiac Arrest (1762)
Event Date 02/12/2015
Event Type  Injury  
Event Description
It was reported that a patient, (b)(6) year old, male, underwent an atrial flutter (afl) procedure with a carto 3 system and received an electrical shock, became asystolic and then went into atrial fibrillation which required hemodynamic support.An ablation catheter that was already in the patient¿s heart was plugged into a reprocessed mapping cable which was already connected to the patient interface unit (piu).Upon connection, there were large amplitude spikes at about 100 ms and signal saturation was noticed throughout all electrocardiograms (ecg), electrograms (egm) and monitoring channels making it unable to see any ecg signal.In addition, there was a "current leakage" alert on the carto 3 system.The patient, who was moderately sedated, received an electric shock for six seconds when the catheter was connected to the cable.It was then noted that the patient became asystolic for approximately three seconds and then spontaneously went into atrial fibrillation.The issue ceased when the cable was detached from the catheter.The cable was replaced and the same catheter was reconnected to the new cable without any errors appearing.Hemodynamic support in the form of vasopressors for approximately 30 minutes was provided to the patient following the incident.The patient was cardioverted and the procedure was continued with no further issues with the patient.The patient also required an overnight stay that was not anticipated.The patient was reported to be in stable condition and was released the next day.The right atrium was about to be mapped and the patient had an existing dual chamber pacemaker that did not capture for a few seconds afterword and then reverted to magnet mode.It was examined afterwards and was found to be in working order.The physician believes there was current transfer from the piu through the ablation catheter.
 
Manufacturer Narrative
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.Concomitant products: coolflow pump (model# m-5491-02 serial# (b)(4)).Biosense webster manufacturer's ref.No.'s (b)(4) are related to the same incident.Contact office and manufacturing site should reflect: (b)(4).Manufacturer's ref.No: (b)(4) event description continuation: the products involved were the ez steer thermocool sf nav catheter, c3 interface cable ¿ therapeutic, carto 3 system and stockert system.It is currently unknown which product contributed to the event and a complete investigation will be done to determine the causative device.
 
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).It was reported that a patient, (b)(6), male, underwent an atrial flutter (afl) procedure with a carto 3 system and received an electrical shock, became asystolic and then went into atrial fibrillation which required hemodynamic support.Field service engineer (fse) performed full functional test with focus on dc voltage and resistance tests.All tests passed with no issue.Fse could not duplicate any problem during testing.System is ready for use.Additional investigation was performed by the device manufacture to the cable and catheter which were involved in the issue.The reported issue was not duplicated while connecting the suspicious catheter extension cable and the original catheter to patient interface unit and checking it with the carto 3 application.The cable and catheter were found to have no effect on ecg signal quality.Proper isolation was found between the cable power lines and cable electrodes lines as well as between the catheter power lines and catheter electrodes lines.Neither cable nor catheter caused leakage current.The history of customer complaints associated with the carto 3 system were reviewed.There was not any additional complaints that may be related to the reported issue.Device history record review was performed by the manufacturer and no anomalies were noted in manufacturing or servicing of this equipment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO® 3 SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 20667 17
IS  2066717
Manufacturer (Section G)
BIOSENSE WEBSTER (ISRAEL) LTD.
4 hatnufah street
yokneam 2066 717
IS   2066717
Manufacturer Contact
jaime chavez
9098398483
MDR Report Key4588107
MDR Text Key5453049
Report Number3008203003-2015-00011
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K133916
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 02/12/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM-4800-01
Device Catalogue NumberFG540000
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/12/2015
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age74 YR
Patient Weight85
-
-